Drug Topics November 3, 2023
Speakers at an AMCP Nexus session provided an in-depth understanding of how changes brought on by the Inflation Reduction Act (IRA) have impacted Medicare, as well as what provisions are to come.
As the implementation of the Inflation Reduction Act (IRA) reaches its first anniversary, speakers at the Academy of Managed Care Pharmacy (AMCP) Nexus meeting recapped the changes that have taken place and mapped out the provisions still to come over the next several years.
Changes including out-of-pocket (OOP) caps for Medicare Part D drugs, price negotiations between Medicare and drug manufacturers, and the implementation of the Medicare Prescription Payment Plan (MPPP) will impact plans, pharmacy benefit managers (PBMs), and patients in different ways. The speakers stressed that collaboration...